Rosner S, Connor S, Sanber K, Zahurak M, et al. Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade. Clin Cancer Res 2025;31:339-351.
PMID: 39545922